Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients

Clinical trial NCT03470961 · UNKNOWN

Trial details

NCT number: NCT03470961
Sponsor: Tianjin First Central Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

CKD (Chronic Kidney Disease) Stage 5T Diabetes Mellitus Simultaneous Pancreas Kidney Transplantation

Start date: 2018-03-01
Primary completion: 2021-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.